Amber Edwards is the new chief commercial officer of Alastin Skincare, effective July 31, 2020. She most recently served as president of Sinclair Pharma North America. Prior to Sinclair, Edwards was the vice president of international strategic marketing at Allergan’s Medical Aesthetics Franchise in the U.K. She began her career in sales and marketing roles at Pfizer.
“We are extremely pleased to have Amber Edwards join Alastin as a key member of the executive team to lead our U.S. and international commercialization activities as we continue the rapid growth of our company,” said Diane S. Goostree, president and CEO of Alastin Skincare. “Amber’s strategic perspectives and global experience will be extremely helpful as we leverage our innovative science and products and expand our footprint in the aesthetic marketplace.”
“I am thrilled to join an organization that has made such a notable mark in a crowded segment, and at a time they are experiencing tremendous opportunity and momentum,” said Edwards. “Alastin has demonstrated a commitment to science and ultimately to patients, identifying an innovative approach to helping physicians maximize patient results. I believe they have only scratched the surface and am honored to lead the commercial path forward.”
